drugset

drugset / Trial / NCT04122547

Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis

NCT04122547 ↗

Phase 3 Completed 40 enrolled Prince of Songkla University

RandomizedParallel-groupTriple-blindTreatment

Summary

Roflumilast compare with placebo for decrease infected exacerbation in non-cystic Bronchiectasis

Timeline

Start: 2015-01
Primary completion: 2015-12
Completion: 2015-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Roflumilast	Small molecule	500 ug	Oral

Indications